Robert M. Snapka
Elsevier Science
e druk, 1996
9780126536300
The SV40 Replicon Model for Analysis of Anticancer Drugs
Specificaties
Gebonden, blz.
|
Engels
Elsevier Science |
e druk, 1996
ISBN13: 9780126536300
Rubricering
Onderdeel van serie
Biotechnology Intelligence Unit
Verwachte levertijd ongeveer 9 werkdagen
Samenvatting
This book provides the most up-to-date review of the simian virus 40 (SV40) minichromosome as a model for the mammalian chromosome in studies of DNA replication. It focuses on disruption of DNA replication by anticancer drugs and DNA-damaging agents. There is a strong emphasis on the unique advantages of SV40 as an experimental system for the analysis of these classes of anticancer drug mechanisms. The new high-resolution gel electrophoresis methods for the analysis of SV40 DNA replication are covered in detail to aid readers in designing and interpreting similar experiments.
Specificaties
Inhoudsopgave
R.M. Snapka, Papovavirus Models for Mammalian Replicons.R.M. Snapka, Analysis of SV40 DNA Replication Intermediates.R.M. Snapka, Catastrophic Failure of DNA Replication Forks: Structural and RecombinationalPathways.R.M. Snapka and E.F. Yamasaki, Topoisomerase II and the Termination of DNA Replication.R.M. Snapka, DNA Damaging Agents.R.M. Snapka, C.A. Ferrar, N.-J. Sun, and J.M. Cassady, Drug Discovery and Evaluation with SV40.L.H. Malkas, Simian Virus 40 (SV40) in Vitro DNA Replication: A Potential Model for Studying Anticancer Drug Action.R.M. Snapka and P.A. Permana, SV40 Circular Oligomer Series: Normal and Abnormal DNA Replication.Subject Index.